Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV

Background: Pulmonary hypertension (PH) is a rare progressive and lethal disease affecting pulmonary arteries and heart function. The disease may compromise the nutritional status of the patient, which impairs their physical performance. This study aimed to determine the prevalence of micronutrient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Paulien Vinke, Thomas Koudstaal, Femke Muskens, Annemien van den Bosch, Michiel Balvers, Mieke Poland, Renger F. Witkamp, Klaske van Norren, Karin A. Boomars
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/3a57317215684dc0b7ea79e57daa9a53
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3a57317215684dc0b7ea79e57daa9a53
record_format dspace
spelling oai:doaj.org-article:3a57317215684dc0b7ea79e57daa9a532021-11-25T18:35:20ZPrevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV10.3390/nu131139232072-6643https://doaj.org/article/3a57317215684dc0b7ea79e57daa9a532021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6643/13/11/3923https://doaj.org/toc/2072-6643Background: Pulmonary hypertension (PH) is a rare progressive and lethal disease affecting pulmonary arteries and heart function. The disease may compromise the nutritional status of the patient, which impairs their physical performance. This study aimed to determine the prevalence of micronutrient deficiencies in pulmonary arterial hypertension (PAH) and chronic thrombo-embolic pulmonary hypertension (CTEPH) patients. Methods: Eighty-one blood samples from a prospective observational cohort study were analyzed for concentrations of micronutrients and inflammation-related factors. The samples consisted of newly diagnosed (treatment-naive) PAH and CTEPH patients and patients treated for 1.5 years according to ERS/ESC guidelines. Results: In the newly diagnosed group, 42% of PAH patients and 21% of CTEPH patients were iron deficient compared to 29% of PAH patients and 20% of CTEPH patients in the treatment group. Vitamin D deficiency occurred in 42% of the newly diagnosed PAH patients, 71% of the newly diagnosed CTEPH patients, 68% of the treated PAH patients, and 70% of the treated CTEPH patients. Iron levels correlated with the 6 min walking distance (6MWD). Conclusions: Iron and vitamin D deficiencies are highly prevalent in PAH and CTEPH patients, underlining the need for monitoring their status. Studies evaluating the effects of supplementation strategies for iron and vitamin D are necessary.Paulien VinkeThomas KoudstaalFemke MuskensAnnemien van den BoschMichiel BalversMieke PolandRenger F. WitkampKlaske van NorrenKarin A. BoomarsMDPI AGarticlepulmonary hypertensionpulmonary arterial hypertensionchronic thrombo-embolic pulmonary hypertensionvitamin Dironmicronutrient deficienciesNutrition. Foods and food supplyTX341-641ENNutrients, Vol 13, Iss 3923, p 3923 (2021)
institution DOAJ
collection DOAJ
language EN
topic pulmonary hypertension
pulmonary arterial hypertension
chronic thrombo-embolic pulmonary hypertension
vitamin D
iron
micronutrient deficiencies
Nutrition. Foods and food supply
TX341-641
spellingShingle pulmonary hypertension
pulmonary arterial hypertension
chronic thrombo-embolic pulmonary hypertension
vitamin D
iron
micronutrient deficiencies
Nutrition. Foods and food supply
TX341-641
Paulien Vinke
Thomas Koudstaal
Femke Muskens
Annemien van den Bosch
Michiel Balvers
Mieke Poland
Renger F. Witkamp
Klaske van Norren
Karin A. Boomars
Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV
description Background: Pulmonary hypertension (PH) is a rare progressive and lethal disease affecting pulmonary arteries and heart function. The disease may compromise the nutritional status of the patient, which impairs their physical performance. This study aimed to determine the prevalence of micronutrient deficiencies in pulmonary arterial hypertension (PAH) and chronic thrombo-embolic pulmonary hypertension (CTEPH) patients. Methods: Eighty-one blood samples from a prospective observational cohort study were analyzed for concentrations of micronutrients and inflammation-related factors. The samples consisted of newly diagnosed (treatment-naive) PAH and CTEPH patients and patients treated for 1.5 years according to ERS/ESC guidelines. Results: In the newly diagnosed group, 42% of PAH patients and 21% of CTEPH patients were iron deficient compared to 29% of PAH patients and 20% of CTEPH patients in the treatment group. Vitamin D deficiency occurred in 42% of the newly diagnosed PAH patients, 71% of the newly diagnosed CTEPH patients, 68% of the treated PAH patients, and 70% of the treated CTEPH patients. Iron levels correlated with the 6 min walking distance (6MWD). Conclusions: Iron and vitamin D deficiencies are highly prevalent in PAH and CTEPH patients, underlining the need for monitoring their status. Studies evaluating the effects of supplementation strategies for iron and vitamin D are necessary.
format article
author Paulien Vinke
Thomas Koudstaal
Femke Muskens
Annemien van den Bosch
Michiel Balvers
Mieke Poland
Renger F. Witkamp
Klaske van Norren
Karin A. Boomars
author_facet Paulien Vinke
Thomas Koudstaal
Femke Muskens
Annemien van den Bosch
Michiel Balvers
Mieke Poland
Renger F. Witkamp
Klaske van Norren
Karin A. Boomars
author_sort Paulien Vinke
title Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV
title_short Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV
title_full Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV
title_fullStr Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV
title_full_unstemmed Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV
title_sort prevalence of micronutrient deficiencies and relationship with clinical and patient-related outcomes in pulmonary hypertension types i and iv
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/3a57317215684dc0b7ea79e57daa9a53
work_keys_str_mv AT paulienvinke prevalenceofmicronutrientdeficienciesandrelationshipwithclinicalandpatientrelatedoutcomesinpulmonaryhypertensiontypesiandiv
AT thomaskoudstaal prevalenceofmicronutrientdeficienciesandrelationshipwithclinicalandpatientrelatedoutcomesinpulmonaryhypertensiontypesiandiv
AT femkemuskens prevalenceofmicronutrientdeficienciesandrelationshipwithclinicalandpatientrelatedoutcomesinpulmonaryhypertensiontypesiandiv
AT annemienvandenbosch prevalenceofmicronutrientdeficienciesandrelationshipwithclinicalandpatientrelatedoutcomesinpulmonaryhypertensiontypesiandiv
AT michielbalvers prevalenceofmicronutrientdeficienciesandrelationshipwithclinicalandpatientrelatedoutcomesinpulmonaryhypertensiontypesiandiv
AT miekepoland prevalenceofmicronutrientdeficienciesandrelationshipwithclinicalandpatientrelatedoutcomesinpulmonaryhypertensiontypesiandiv
AT rengerfwitkamp prevalenceofmicronutrientdeficienciesandrelationshipwithclinicalandpatientrelatedoutcomesinpulmonaryhypertensiontypesiandiv
AT klaskevannorren prevalenceofmicronutrientdeficienciesandrelationshipwithclinicalandpatientrelatedoutcomesinpulmonaryhypertensiontypesiandiv
AT karinaboomars prevalenceofmicronutrientdeficienciesandrelationshipwithclinicalandpatientrelatedoutcomesinpulmonaryhypertensiontypesiandiv
_version_ 1718410946145157120